These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34977339)

  • 1. Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma.
    Zhang C; Fang L; Wang X; Yuan S; Li W; Tian W; Chen J; Zhang Q; Zhang Y; Zhang Q; Zheng J
    Mol Ther Oncolytics; 2022 Mar; 24():14-25. PubMed ID: 34977339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma.
    Fang L; Tian W; Zhang C; Wang X; Li W; Zhang Q; Zhang Y; Zheng J
    Pharmacol Res; 2023 Mar; 189():106701. PubMed ID: 36796464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models.
    Li H; Ding J; Lu M; Liu H; Miao Y; Li L; Wang G; Zheng J; Pei D; Zhang Q
    J Immunother; 2020 Jan; 43(1):16-28. PubMed ID: 31574023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabozantinib enhances CAIX specific CAR-T cells against renal cancer by improving effector functions and augmenting tumor immune microenvironment.
    Li Q; Yang L; Li S; Zhao W; Xue Y; Lu Z; Tang J; Gao X; Zheng J; Zhang Q; Sun S
    Biochem Biophys Res Commun; 2024 Nov; 734():150781. PubMed ID: 39368372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.
    Cui J; Zhang Q; Song Q; Wang H; Dmitriev P; Sun MY; Cao X; Wang Y; Guo L; Indig IH; Rosenblum JS; Ji C; Cao D; Yang K; Gilbert MR; Yao Y; Zhuang Z
    Neuro Oncol; 2019 Nov; 21(11):1436-1446. PubMed ID: 31276594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects.
    Wang Y; Buck A; Piel B; Zerefa L; Murugan N; Coherd CD; Miklosi AG; Johal H; Bastos RN; Huang K; Ficial M; Laimon YN; Signoretti S; Zhong Z; Hoang SM; Kastrunes GM; Grimaud M; Fayed A; Yuan HC; Nguyen QD; Thai T; Ivanova EV; Paweletz CP; Wu MR; Choueiri TK; Wee JO; Freeman GJ; Barbie DA; Marasco WA
    Mol Cancer; 2024 Mar; 23(1):56. PubMed ID: 38491381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer.
    Li Y; Xiao F; Zhang A; Zhang D; Nie W; Xu T; Han B; Seth P; Wang H; Yang Y; Wang L
    Cell Immunol; 2020 Feb; 348():104041. PubMed ID: 31983398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors.
    Ding J; Zheng Y; Zhu F; Wang M; Fang L; Li H; Tian H; Liu Y; Wang G; Zheng J; Chai D
    Int Immunopharmacol; 2023 Oct; 123():110722. PubMed ID: 37573687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
    Oh E; Choi IK; Hong J; Yun CO
    Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell Carcinoma.
    Zhang W; Zhang C; Tian W; Qin J; Chen J; Zhang Q; Fang L; Zheng J
    Hum Gene Ther; 2020 Jun; 31(11-12):651-663. PubMed ID: 32216478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors.
    Su Y; Li J; Ji W; Wang G; Fang L; Zhang Q; Ang L; Zhao M; Sen Y; Chen L; Zheng J; Su C; Qin L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35609942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors.
    Tang X; Li Y; Ma J; Wang X; Zhao W; Hossain MA; Yang Y
    Cancer Lett; 2020 Sep; 487():1-9. PubMed ID: 32454143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma.
    Cui J; Wang H; Medina R; Zhang Q; Xu C; Indig IH; Zhou J; Song Q; Dmitriev P; Sun MY; Guo L; Wang Y; Rosenblum JS; Kovach JS; Gilbert MR; Zhuang Z
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model.
    Wang Y; Buck A; Grimaud M; Culhane AC; Kodangattil S; Razimbaud C; Bonal DM; Nguyen QD; Zhu Z; Wei K; O'Donnell ML; Huang Y; Signoretti S; Choueiri TK; Freeman GJ; Zhu Q; Marasco WA
    Mol Ther Oncolytics; 2022 Mar; 24():385-399. PubMed ID: 35118195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors.
    Fang L; Yuan S; Wang M; Zhang C; Wang X; Li H; Yang J; Li W; Sun N; Zhang Q; Zhang Y; Chai D; Li H; Zheng J; Wang G
    Cell Death Discov; 2023 Sep; 9(1):328. PubMed ID: 37660142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy.
    Campos NSP; Souza BS; Silva GCPD; Porto VA; Chalbatani GM; Lagreca G; Janji B; Suarez ER
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-tagging by oncolytic viruses: A novel strategy for CAR-T therapy against solid tumors.
    Tang XY; Ding YS; Zhou T; Wang X; Yang Y
    Cancer Lett; 2021 Apr; 503():69-74. PubMed ID: 33476650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells.
    Lamers CH; Willemsen R; van Elzakker P; van Steenbergen-Langeveld S; Broertjes M; Oosterwijk-Wakka J; Oosterwijk E; Sleijfer S; Debets R; Gratama JW
    Blood; 2011 Jan; 117(1):72-82. PubMed ID: 20889925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.